The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance ...

Time and sensitivity are essential for analytical technologies in all phases of biopharma development. Although just a few decades old, the biopharmaceutical industry has evolved significantly since ...

Expansive growth in the gene and cell therapy (GCT) space has led to developers and manufacturers facing a multitude of challenges on the road to commercialization. To overcome issues associated with ...

In today’s pharmaceutical environment, where compliance and speed-to-market are paramount, analytical method development and validation play a foundational role. From early research through to GMP ...

CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex ...

The 2nd Cell Therapy Analytical Development Summit Europe is an unmissable event for Europe's top biotech and pharma! As the cell therapy industry continues to rapidly grow and evolve, the opportunity ...

Each department, from production to clinical research, deals with three types of work: maintenance, routine, and project work. The work shares vary with the nature of the work, but all departments ...

The 2nd CRISPR-Based Therapy Analytical Development Summit is returning to Boston this September to unite 50+ key figures across Analytical Development, CMC & QC domains, all with the common goal of ...